News from Apogenix A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 28, 2015, 09:00 ET

Apogenix Enters into Cooperation with R-Biopharm to Develop Companion Diagnostic Tests for Immuno-Oncology Candidate APG101

Apogenix, a next generation immuno-oncology company, announced today that it has entered into an agreement with R-Biopharm, a global provider of...

Jul 15, 2015, 08:00 ET

Apogenix Enters into Licensing Agreement with CANbridge Life Sciences for Immuno-Oncology Candidate APG101 in China

 Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge...

Jun 03, 2015, 09:00 ET

Apogenix appoints Peter Willinger as new CFO

 Apogenix, a next generation immuno-oncology company, announced today the appointment of Peter Willinger as Chief Financial Officer. As head of...

Jun 01, 2015, 09:00 ET

Apogenix to present at Jefferies 2015 Global Healthcare Conference

 Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will present at the...

Oct 28, 2014, 09:00 ET

Apogenix - Positive Results from APG101 Phase II Clinical Trial Published in Clinical Cancer Research

 Apogenix, a clinical stage biopharmaceutical company, announced today that the final data of the completed phase II clinical trial with APG101...

Jan 13, 2014, 09:00 ET
Jan 07, 2014, 09:00 ET

Apogenix to Present Phase II Results with APG101 for the Treatment of Recurrent Glioblastoma at Biotech Showcase in San Francisco

 Apogenix, a clinical stage biopharmaceutical company, announced today that Thomas Hoeger, Ph.D., Chief Executive Officer, will...

Dec 05, 2013, 09:00 ET

Apogenix' APG350 Effectively Induces Apoptosis of Tumor Cells via TRAIL Pathway Independent of Fc-gamma Cross-Linking

 Apogenix, a clinical stage biopharmaceutical company, announced today that the data published in the December issue of Molecular Cancer...

Jul 02, 2013, 09:00 ET

Apogenix Strengthens Patent Position for Apocept™ (APG101) in Europe and Canada

 Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...

Feb 07, 2013, 09:00 ET

Apogenix Receives FDA Orphan Drug Designation for Apocept™ to Treat Myelodysplastic Syndromes and Initiates Clinical Phase I Study

Apogenix GmbH, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...

Nov 06, 2012, 04:00 ET

Apogenix's Apocept™ for Glioblastoma Multiforme Named One of "Top 10 Projects to Watch"

Apogenix, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory...